Cadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to Mallinc...
12 Febbraio 2014 - 5:26PM
Business Wire
Former United States Securities and Exchange Commission attorney
Willie Briscoe and the securities litigation firm of Powers Taylor
LLP are investigating potential claims against the Board of
Directors of Cadence Pharmaceuticals Inc. (“Cadence”) (NasdaqGS:
CADX) related to the sale to Mallinckrodt plc for shareholders.
Cadence shareholders will receive just $14.00 in cash for each
share owned under the terms of the transaction, which is well below
an analyst estimated $15.00 per share.
If you are an affected investor, and you want to learn more
about the lawsuit or join the action, contact Willie Briscoe at The
Briscoe Law Firm, PLLC, (214) 239-4568, or via email at
WBriscoe@TheBriscoeLawFirm.com, or Patrick Powers at Powers Taylor
LLP, toll free (877) 728-9607, via e-mail at
shareholder@powerstaylor.com. There is no cost or fee to you.
The Cadence investigation centers on whether Cadence’s Board of
Directors is acting in the shareholders’ best interests, whether
the board is properly considering the proposed price for the
shareholders, and whether the board has employed an adequate
process to review and act on the proposed transaction. Notably, at
least one analyst with Yahoo! Finance estimates the Company could
be worth as high as $15 per share.
The Briscoe Law Firm, PLLC is a full service business litigation
and shareholder rights advocacy firm with more than 20 years of
experience in complex litigation and transactional matters.
Powers Taylor LLP is a boutique litigation law firm that handles
a variety of complex business litigation matters, including claims
of investor and stockholder fraud, shareholder oppression,
shareholder derivative suits, and security class actions.
The Briscoe Law Firm, PLLCWillie Briscoe,
214-239-4568WBriscoe@TheBriscoeLawFirm.comorPowers Taylor
LLPPatrick Powers, 877-728-9607shareholder@powerstaylor.com
Grafico Azioni (MM) (NASDAQ:CADX)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni (MM) (NASDAQ:CADX)
Storico
Da Set 2023 a Set 2024
Notizie in Tempo Reale relative a (MM) (NASDAQ): 0 articoli recenti
Più Cadence Pharmaceuticals, Inc. (MM) Articoli Notizie